Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Advances in Cancer Research
|
November 5, 1999
p53 and human cancer: the first ten thousand mutations
P Hainaut, M Hollstein
Annual Review of Medicine
|
January 1, 1996
Clinical implications of the p53 gene
D Sidransky, M Hollstein
The New England Journal of Medicine
|
October 28, 1993
Clinical implications of the p53 tumor-suppressor gene
C C Harris, M Hollstein
Cell Death and Differentiation
|
April 30, 2003
Mouse models with modified p53 sequences to study cancer and ageing
A R Clarke, M Hollstein
Biochemical Pharmacology
|
June 1, 1976
Mutagenicity of 8-hydroxyquinoline and related compounds in the Salmonella typhimurium bioassay
R Talcott, M Hollstein, E Wei
International Journal of Cancer
|
June 21, 1996
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review
R Montesano, M Hollstein, P Hainaut
Journal of the National Cancer Institute
|
February 1, 1978
Quinoline: conversion to a mutagen by human and rodent liver
M Hollstein, R Talcott, E Wei
Carcinogenesis
|
May 1, 1988
Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects
L Giroldi, M Hollstein, H Yamasaki
Nucleic Acids Research
|
November 11, 1986
Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients
M Hollstein, R Montesano, H Yamasaki
Biochimica Et Biophysica Acta
|
December 8, 2004
Differential effect of imipramine and related compounds on Mg2+ efflux from rat erythrocytes
H Ebel, M Hollstein, T Günther
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Advances in Cancer Research
|
November 5, 1999
p53 and human cancer: the first ten thousand mutations
P Hainaut, M Hollstein
Annual Review of Medicine
|
January 1, 1996
Clinical implications of the p53 gene
D Sidransky, M Hollstein
The New England Journal of Medicine
|
October 28, 1993
Clinical implications of the p53 tumor-suppressor gene
C C Harris, M Hollstein
Cell Death and Differentiation
|
April 30, 2003
Mouse models with modified p53 sequences to study cancer and ageing
A R Clarke, M Hollstein
Biochemical Pharmacology
|
June 1, 1976
Mutagenicity of 8-hydroxyquinoline and related compounds in the Salmonella typhimurium bioassay
R Talcott, M Hollstein, E Wei
International Journal of Cancer
|
June 21, 1996
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review
R Montesano, M Hollstein, P Hainaut
Journal of the National Cancer Institute
|
February 1, 1978
Quinoline: conversion to a mutagen by human and rodent liver
M Hollstein, R Talcott, E Wei
Carcinogenesis
|
May 1, 1988
Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects
L Giroldi, M Hollstein, H Yamasaki
Nucleic Acids Research
|
November 11, 1986
Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients
M Hollstein, R Montesano, H Yamasaki
Biochimica Et Biophysica Acta
|
December 8, 2004
Differential effect of imipramine and related compounds on Mg2+ efflux from rat erythrocytes
H Ebel, M Hollstein, T Günther
Page
of 9